title: Increased osteoblast adhesion on nanoparticulate crystalline hydroxyapatite functionalized with KRSR.
abstract: The present in vitro study created nanometer crystalline hydroxyapatite (HA) and amorphous calcium phosphate for novel orthopedic applications. Specifically, nano-crystalline HA and amorphous calcium phosphate nanoparticles were synthesized by a wet chemical process followed by hydrothermal treatment for 2 hours at 200 degrees C and 70 degrees C, respectively. Resulting particles were then pressed into compacts. For the preparation of control conventional HA particles (or those currently used in orthopedics with micron diameters), the aforementioned calcium phosphate particles were pressed into compacts and sintered at 1100 degrees C for 2 hours. All calcium phosphate-based particles were fully characterized. Results showed that although there was an initial weight gain for all the compacts studied in this experiment, higher eventual degradation rates up to 3 weeks were observed for nano-amorphous calcium phosphate compared with nano-crystalline HA which was higher than conventional HA. Peptide functionalization (with the cell adhesive peptide lysine-arginine-serine-arginine [KRSR] and the non-cell-adhesive peptide lysine-serine-arginine-arginine [KSRR]) was accomplished by means of a three-step reaction procedure: silanization with 3-aminopropyltriethoxysilane (APTES), cross-linking with N-succinimidyl-3-maleimido propionate (SMP), and finally peptide immobilization. The peptide functionalization was fully characterized. Results demonstrated increased osteoblast (bone-forming cell) adhesion on non-functionalized and functionalized nano-crystalline HA compacts compared with nano amorphous calcium phosphate compacts; both increased osteoblast adhesion compared with conventional HA. To further exemplify the novel properties of nano crystalline HA, results also showed similar osteoblast adhesion between non-functionalized nano crystalline HA and KRSR functionalized conventional HA. Thus, results provided evidence that nanocrystalline HA should be further studied for orthopedic applications.
authors: Department of Chemical Engineering, Michigan State University, East Lansing, MI, USA.
authors: Michael
authors: M
authors: Nelson
authors: Ganesan
authors: G
authors: Balasundaram
authors: Thomas J
authors: TJ
authors: Webster
mesh_terms: D000327:Adsorption; D002130:Calcium Phosphates; D002448:Cell Adhesion / Q000502:physiology*; D018929:Cell Culture Techniques / Q000379:methods*; D002460:Cell Line; D020099:Coated Materials, Biocompatible / Q000737:chemistry; D003460:Crystallization / Q000379:methods; D017886:Durapatite / Q000737:chemistry*; D006801:Humans; D008422:Materials Testing; D049329:Nanostructures / Q000737:chemistry* / Q000648:ultrastructure; D009842:Oligopeptides / Q000008:administration & dosage* / Q000737:chemistry; D016348:Osseointegration / Q000187:drug effects / Q000502:physiology; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D010316:Particle Size; D011485:Protein Binding; D023822:Tissue Engineering / Q000379:methods*
chemical_list: D002130:Calcium Phosphates; D020099:Coated Materials, Biocompatible; D009842:Oligopeptides; C519480:amorphous calcium phosphate; C437191:lysyl-arginyl-seryl-arginine; D017886:Durapatite
references: Biomaterials. 2000 Apr;21(7):667-81
references: 10711964
references: Biomaterials. 2001 Jun;22(11):1327-33
references: 11336305
references: Biomaterials. 2002 Oct;23(19):3937-42
references: 12162326
references: Foot Ankle Clin. 2002 Mar;7(1):19-41
references: 12380379
references: Tissue Eng. 2002 Oct;8(5):753-61
references: 12459054
references: J Oral Implantol. 2002;28(6):290-4
references: 12498538
references: Cell Mol Life Sci. 2003 Jan;60(1):119-32
references: 12613662
references: J Bone Joint Surg Am. 2003;85-A Suppl 3:75-81
references: 12925613
references: Biomaterials. 2004 Aug;25(19):4731-9
references: 15120519
references: Biomaterials. 2005 Apr;26(12):1349-57
references: 15482822
references: Science. 1987 Oct 23;238(4826):491-7
references: 2821619
references: Bone Miner. 1992 Sep;18(3):215-26
references: 1392695
references: J Bone Miner Res. 1993 May;8(5):527-33
references: 8511980
references: J Pharm Sci. 1994 Feb;83(2):259-63
references: 8169801
references: J Orthop Res. 1994 May;12(3):384-94
references: 8207592
references: Exp Cell Res. 1994 Sep;214(1):264-9
references: 7521844
references: J Cell Sci. 1995 May;108 ( Pt 5):2083-92
references: 7657726
references: J Bone Joint Surg Br. 1997 Mar;79(2):240-6
references: 9119850
references: Biomaterials. 1997 Sep;18(18):1201-25
references: 9300556
references: J Biomed Mater Res. 1997 Oct;37(1):9-19
references: 9335344
references: J Biomed Mater Res. 1998 Jun 5;40(3):371-7
references: 9570067
references: Biomaterials. 2005 Jun;26(18):3995-4021
references: 15626447
references: J Biomed Mater Res A. 2005 Sep 15;74(4):677-86
references: 16035065
references: Biomaterials. 2006 May;27(14):2798-805
references: 16430957